Upload
others
View
2
Download
0
Embed Size (px)
Citation preview
Endocrinol.Japon.1989,36(4), 459-464
Isolated ACTH Deficiency Associated with TransientThyrotoxicosis and Hyperprolactinemia
YOSHIFUMI KANEMARU, TOSHIKAZU NOGUCHI AND TOSHIMASA ONAYA
The Third Department of Internal Medicine, Universityof Yamanashi Medical School, Tamaho, Yamanashi 409-38, Japan
Abstract
A 43-year-old woman with isolated ACTH deficiency in association withtransient thyrotoxicosis is reported. The initial evaluation revealed that plasmaACTH and cortisol did not respond to corticotropin-releasing hormone (CRH)in the presence of hyperthyroxinemia and hyperprolactinemia. During thereplacement therapy with dexamethasone, she developed transient hypothyroxi-nemia with persistent hyperprolactinemia. Although thyroid open biopsy didnot show any evidence of autoimmune thyroiditis or subacute thyroiditis, thedata appear to provide other evidence of a possible relationship betweenacute adrenal insufficiency and transient thyroid dysfunction.
Isolated ACTH deficiency is a rare causeof adrenocortical insufficiency, which is notfrequently associated with other endocrineabnormalities. There have been severalreports of isolated ACTH deficiency inassociation with some thyroid dysfunctionssuggesting that an autoimmune process maybe directed against both the pituitary andthe thyroid gland (Richtsmeier et al., 1980).On the other hand, we have previouslyreported two cases of transient thyrotoxicosisafter unilateral adrenalectomy due to
Cushing's syndrome (Haraguchi, et al. 1984).In this paper we report a case of isolatedACTH deficiency associated with transientthyrotoxicosis and hyperprolactinemia.
Materials and Methods
Plasma ACTH was measured by RIA usingthe CIS ACTH radioimmunoassay kit (AtomicEnergy Laboratory of Biomedical Products,France). The sensitivity of the assay of ACTHwas 10pg/ml. Prolactin (PRL), LH, FSH, GH,triiodothyronine (T3), thyroxine (T4) and cortisollevels were determined by RIA. TSH wasmeasured by highly sensitive TSH immuno-radiometric assay with a commercially availablekit. Urinary 17-OHCS was measured by theSilber-Porter reaction and 17-KS by the Zim-mermann reaction. Anti-TSH receptor antibodywas determined with a Smith's kit. Autoanti-bodies for anterior pituitary cell surface mem-brane (PitCSA) were assayed by an immuno-fluorescence method with GH3 ce11 (rat GH and
prolactin secreting cell) and AtT-20 cells (mouseadrenocorticotropic hormone secreting cell) asantigens. Briefly, the diluted sera and cell sus-pension were mixed. After adding FITC-labelledanti-human IgG solution, the cell suspensionwas examined under an incident fluorescence
Received October 4, 1988
Requests for reprints should be addressed to
YOSHIFUMI KANEMARU.
460 KANEMARU et al.Endocrinol. Japon.August 1989
microscope (Sugiura et al., 1987). Anti-adrenalantibody was determined by a tissue substrate-indirect immunofluorescence method. Briefly,cryostat sections of adrenal gland were reactedwith dilutions of patient's serum, rinsed andreacted with fluoresceinated anti-human immuno-
globulin conjugate. Patterns were compared tocontrols (Bigazzi PE et al., 1968).
ACTH-Z and lysine vasopressin were ad-ministered intramuscularly. Insulin (0.1unit/kg),corticotropin-releasing hormone (CRH, 100pg) ,LH-releasing hormone (LH-RH, 100pg) , andthyrotropin-releasing hormone (TRH, 500mg)were injected intravenously. CRH was gener-ously donated by Dr. Shibazaki, Department ofMedicine, Tokyo Women's Medical college .
Case Report and Results
A 43-year-old housewife was admitted
to the hospital in May, 1987 complaining
chiefly of nausea, vomiting, and headache
that had persisted for 3 weeks. She also
complained of general weakness and diz-
ziness. Without any medication, these
symptoms disappeared spontaneously. The
family history and the past history were
noncontributory. Her menses had been
regular. She was married at the age of 24
and had two children after normal preg-
nancies without any abnormal postpartum
galactorrhea. She had never been on medi-cine until this admission.
On admission, she was asthenic, but
conscious. She was 151.6cm tall and
weighed 47.6kg. No pigmentation was
Table 1. Thyroid function and PRL be-fore and after administrationof dexamethasone (0.5mg/day)
observed in the skin or mucous membranes.
There was a normal distribution of body
hair, and the goiter was not palpable with-
out tenderness. The blood pressure was
88/60mmHg, pulse rate 108/min, and body
temperature 37.2•Ž.
Laboratory data (blood) were as follows:
Erythrocyte sedimentation rate, 35mm/h;
glucose, 115mg/dl; total serum protein,
6.2g/dl; ZTT, 8.8 units; TTT, 3.8 units;
total bilirubin, 0.65mg/dl; total cholesterol,
99 mg/dl; urea nitrogen, 16.8mg/dl; crea-
tinine, 0.5mg/dl; GOT, 206 units/1; GPT,
223 units/1; LDH, 554 units/1; ALP, 289
units/1; r-GTP, 59 units/1; sodium 139.5
mEq/l; potassium, 3.9 mEq/1 ; chloride,
104.8 mEq/1; cortisol, less than 1.0pg/dl
(normal 3.7-13.0); ACTH, less than 10
pg/ml (less than 50); T4, 13.9pg/dl (4.5-
13.0); T3, 2.5ng/ml (0.8-1.8); free T4 was
3.54ng/dl (0.85-2.15); free T3, 8.8pg/ml
(3.0-5.8); TSH, less than 0.1pU/ml (0.6-
5.1); PRL, 130ng/ml (less than 30); serum
thyroglobulin, 13ng/ml (less than 30); and
thyroxine binding globulin, 19 pg/ml (11-
27). Antithyroid, anti-TSH receptor and
antiadrenal antibodies were negative. Al-
though autoantibodies to GH3 cells were
negative, autoantibodies to AtT-20 cells were
positive.
Corticosteroid replacement therapy (dex-
amethasone, 0.5mg/day, orally) has resulted
in the complete elimination of the clinical
symptoms with normalization of liver func-
tion abnormalities although thyroid function
Table 2. Response to ACTH-Z.
Vol.36, No.4 ACTH DEFICIENCY AND THYROTOXICOSIS 461
has fluctuated. T4, T3 and free T4 levels
decreased from 13.9ƒÊg/dl, 2.5ng/ml and
3.54ng/dl to 2.6ƒÊg/dl, 0.5ng/ml and 0.59
ng/dl, respectively, after dexamethasone
administration (0.5mg/day) for 4 weeks
(Table 1). 123I-Uptake after 4 weeks'
dexamethasone replacement (0.5mg/day)
was 5.5% and 21.3%, at 3h, and 24h,
respectively. Eight weeks later, thyroid
function also normalized without T4 re-
placement (T4, 6.1ƒÊg/dl; T3, 0.9ng/ml;
free T4, 0.9ng/dl; TSH, 4.2ƒÊU/ml). Plasma
PRL also decreased 2 weeks after dexame-
thasone administration (0.5mg/day) but
still showed an excessive response to TRH
(Tables 1 and 4).
The pituitary fossa appeared normal in
size, and intact in plain skull radiographs.
High resolution CT and magnetic resonance
imaging (MRI) showed no abnormality in
the skull or sella turcica.
Basal urinary 17-OHCS, 17-KS and
plasma cortisol were subnormal but showed
good responses to the daily administration
of ACTH-Z (Table 2). No response of
Table 3. ACTH response to various tests.
plasma ACTH to im injection of lysine
vasopressin, insulin-induced hypoglycemia
and iv infusion of CRF were observed,
whereas serum GH response to insulin-
induced hypoglycemia was normal (Table
3). Serum LH and FSH responded normally
to LH-RH (Table 4). Serum TSH showed
different responses to TRH during dexa-
methasone replacement therapy (0.5mg/day).
Serum TSH remained very low during hy-
perthyroxinemia, while serum TSH showed
a slightly exaggerated response to TRH
during hypothyroxinemia. Although the
basal value for PRL fell, PRL still showed
an excessive response to TRH (Table 4).
The thyroid open biopsy was carried out
50 days after dexamethasone administration
(0.5mg/day) during the euthyroid state (T4,
5.6ƒÊg/dl; T3, 1.0ng/ml; free T4, 0.83
ng/dl; TSH, 4.2ƒÊU/ml). Histological exa-
mination showed the thyroid follicles to be
small and irregular in size. There was no
fibrosis of the interstices or infiltration of
neutrophils and lymphocytes. These findings
were compatible neither with those of
Table 4. Response to LH-RH and TRH.
462 KANEMARU et al.Endocrinol. Japon.August 1989
Fig. 1. Biopsy specimen of the thyroid gland. The thyroid follicles were small and irregular
in size. There was no fibrosis of the interstices or infiltration of lymphocytes (Hematoxylin
and eosin; magnification,•~200.
Hashimoto's thyroiditis nor subacute thy-roiditis. (Fig. 1)
Discussion
Impairment of adrenocortical functionin ACTH deficiency is often due to pituitaryinvolvement by tumor or non-neoplasticinfiltration, and is frequently accompaniedby deficiencies of other pituitary hormones.
In this case, the headache, fever anddizziness for a couple of weeks beforeadmission may indicate pituitary apoplexy,a condition known to cause empty sellaand hypopituitarism, including isolatedACTH deficiency (Pelkonen et al., 1978).The patient had hyperprolactinemia, whichcould be due to an infarcted tumor, or
primary empty sella (Gharib et al., 1983).CT and MRI, however, showed no ab-normality in the skull and sella turcica.
Several studies have shown that both basaland induced PRL response in man andanimals can be inhibited by the administra-tion of glucocorticoid (Copinschi et al., 1975;Sowers et al., 1977; Lantigua et al., 1980).In addition, Shibutani et al. (1988) recentlyreported that the increased basal PRL andPRL hyperresponsiveness in a case of isolatedACTH deficiency returned to normal afterglucocorticoid replacement.
The possible etiological associations withisolated ACTH deficiency include primaryhypothyroidism (Yamamoto et al., 1976;Miller et al., 1982), insulin-dependent dia-betes mellitus (Abramson et al., 1968), andpolyglandular 'failure (thyroiditis, diabetes,hypoparathyroidism)(Kojima et al., 1982),all of which suggest a possible autoimmunemechanism. Richtsmeier et al. (1980) havedescribed selective ACTH deficiency as apart of an autoimmune syndrome whichcomprises lymphoid hypophysitis and thy-
Vol.36, No.4 ACTH DEFICIENCY AND THYROTOXICOSIS 463
roiditis. In their case, the patient had silent
thyroiditis with postpartum thyrotoxicosis,
a probable variant of chronic lymphocytic
thyroiditis.
In the present case, isolated ACTH de-
ficiency was accompanied bytransient thy-
rotoxicosis and liver dysfunction. Boththyroid and liver functions normalized with
glucocorticoid replacement therapy. Anti-thyroid, anti-TSH receptor and antiadrenalantibodies were negative. Although auto-antibodies to GH3 cells were negative, thoseto AtT-20 cells were positive. Sugiura etal. (1987) have described the incidence ofautoantibodies to AtT-20 cells among 5ACTH deficient patients. In their cases,all of the sera were positive for antibodiesto AtT-20 cells. Although the precise re-lationship between transient thyrotoxicosisand hypocorticalism is unclear, there areseveral lines of evidence showing that acute-ly altered adrenal function can elicit transientthyrotoxicosis (Maruyama et al., 1982,Haraguchi et al., 1984). Maruyama et al.(1982) reported a transient thyrotoxicosiswhich occurred after the cessation of steroidtherapy in a patient with autoimmunethyroiditis and rheumatoid arthritis. Hara-
guchi et al. (1984) reported transient thy-rotoxicosis in two patients with Cushing'ssymdrome who had undergone unilateraladrenalectony. They suggested that im-munological changes enhanced by a reduc-tion in the steroid hormone concentrationmight be closely related to the occurrenceof transient thyrotoxicosis in chronic lym-
phocytic thyroidits.In the present study the data appear to
provide additional evidence of the possiblerelationship between acute adrenal insuffici-ency and transient thyroid dysfunction. Onthe other hand, it is also likely that isolatedACTH deficiency could be a part of anautoimmune syndrome.
References
Abramson, E. A. and R. A. Arky (1968).Coexistent diabetes mellitus and isolatedACTH deficiency: report of a case. Metabo-lism 17, 492-495.
Bigazzi PE, et al.(1968). Immunofluorescencestudies on Addison's disease. hit. Arch Ablergy34, 455-469.
Copinschi, G., M. L'Hermite, R. Leclercq, J.Golstein, K. Vanhaelst, E. Virasoro and C.Robyn (1975). Effect of glucocorticoids on
pituitary hormonal responses to hypoglycemia.Inhibition of prolactin release. J. Clin. Endo-crinol. Metab. 40, 442-449.
Gharib, H., H. M. Frey, E. R. Jr. Laws, R.V. Randall and B. W. Scheithauer (1983).Coexistent primary empty sella syndrome andhyperprolactinemia. Arch. Intern. Med. 143,1383-1386.
Haraguchi, K., K. Hiramatsu and T. Onaya
(1984). Transient thyrotoxicosis after uni-lateral adrenalectomy in two patients withCushing's Syndrome. Endocrinol. Japon. 31,577-582.
Kojima, I., I. Nejima and E. Ogata (1982).Isolated adrenocorticotropin deficiency associ-ated with polyglandular failure. J. Clin.Endocrinol. Metab. 54, 182-186.
Lantigua, R. A., W. F. Strech, K. H. Lock-wood and L. Jacobs (1980). Glucocorticoidsuppression of pancreatic and pituitary hor-mones: Pancreatic polypeptide, growth hor-mone, and prolactin. J. Clin. Endocrinol.Metab. 50, 298-303.
Maruyama, H., M. Kato, O. Mizuno, K. Kata-oka and S. Matsuki (1982). Transient thyro-toxicosis occurred after cessation of steroidtherapy in a patient with autoimmune thy-roiditis and rheumatoid arthritis. Endocrinol.Japon. 29, 583-588.
Miller, M. J. and T. V. Horst (1982). IsolatedACTH deficiency and primary hypothyroidism.Acta. Endocrinol. 99, 573-576.
Pelkonen, R., A. Kuusisto, J. Salmi, P. Eistola,C. Raitta, S. L. Karonen and Aro Antti (1978).Pituitary function after pituitary apoplexy.Am. J. Med. 65, 773-778.
Richtsmeier, A. J., R. A. Henry, J. M. B. Jr.Bloodworth and E. N. Ehrlich (1980). Lym-
phoid hypophysitis with selective adrenocor-ticotropic hormone deficiency. Arch. Intern.
464 KANEMARU et al.Endocrinol. Japon.August 1989
Med. 140, 1243-1245.Shibutani, Y.(1988). Case report: Prolactin
dynamics in a patient with isolated ACTHdeficiency accompanied by hyperprolactinemia.Am. J. Med. 295, 140-143.
Sowers, J. R., H. E. Carlson, N. Brautbar andJ. M. Hershman (1977). Effect of dexametha-sone on prolactin and TSH responses to TRHand metoclopamide in man. J. Clin. Endo-crinol. Metab. 44, 237-241.
Sugiura, M., A. Hashimoto, M. Shizawa, M.
Tsukada, T. Saito, H. Hayami, S. Maruyamaand T. Ishido (1987). Detection of antibodiesto anterior pituitary cell surface membranewith insulin dependent diabetes mellitus andadrenocorticotropic hormone deficiency. Dia-betes. Res. 4, 63-66.
Yamamoto, T., T. Ogihara, K. Miyai, Y.Kumahara and Y. Hirata (1976). Coexistent
primary hypothyroidism and isolated ACTHdeficiency. Acta. Endocrinol. 82, 467-474.